In addition to reducing basal TfR1 and elevating Fpn in activated CF MDMs, we observed that ex vivo pretreatment with modulators robustly impacted CF MDM iron sequestration and biofilm formation of DH1137 (Figs. 3b, 4c). Here, TFRC is linked to cystic fibrosis.